| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Nanostructures in therapeutic medicine series |
|
Nanostructures in therapeutic medicine series.
|
| Contents |
1. Antimicrobials: Meeting challenges of antibiotic resistance and drug delivery Sanjukta Patra 2. Nano-antimicrobials: Activity, benefits and weaknesses Josef Jampilek 3. Sensitive And Selective Assay Of Antimicrobials On Nanostructured Materials By Electrochemical Techniques Sibel A. Özkan 4. Antimicrobial Polymeric Nanostructures Juan Rodriguez-Hernandez 5. Thin degradable coatings for optimization of osteointegration associated with simultaneous infection prophylaxis Anke Bernstein 6. Nanostructure and Nanomedicine of Anti-microbial Agents for Neuroinfectious of Neurodegenerative Diseases: Current and Future Perspectives Arunachalam Muthuraman 7. Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery Asuman BOZKIR 8. |
|
Delivery of Antimicrobials by Chitosan Composed Therapeutic Nanostructures Souto Eliana 9. Antimicrobial thin coatings prepared by laser processing Alexandru Mihai Grumezescu 10. Antimicrobial Photo Dynamic Therapy With Nanoparticle Vs Conventional Photosensitizer In Oral Diseases Reza Fekrazad 11. The Applications of 19F Magnetic Resonance Spectroscopy and Imaging for the Study of Nanostructures used in Antimicrobial Therapy Dorota Bartusik 12. Esential oils and nanoparticles: new strategy to prevent microbial biofilms Alexandru Mihai Grumezescu 13. Nanocarriers Assisted Antimicrobial Therapy Against Intracellular Pathogens Neelesh K. Mehra 14. Implications, Mechanisms and Applications of Nanomaterials with Antimicrobial Properties Alexandru Mihai Grumezescu 15. |
|
Outer Membrane Vesicles Of Gram-Negative Bacteria: Nanoware For Combat Against Microbes And Macrobes Rakesh Chander YashRoy 16. Organic nanocarriers for the delivery of anti-infective agents Jan Sobczyski 17. Nanocarriers for plant-derived natural compounds Oguz Bayraktar 18. Fullerene derivatives in photodynamic inactivation of microorganisms Edgardo N. Durantini 19. Silver iodide (AgI) nanoparticles as an anti-biofilm agent. A case study on gram-negative biofilm forming bacteria Marikani Kannan 20. Nanoformulations for the Therapy of Pulmonary Infections Vandana Bharat Patravale 21. Nanocarriers for photosensitizers for use in the antimicrobial photodynamic therapy Jan Sobczyski 22. |
|
Zinc oxide nanostructures: new trend in antimicrobial therapy Alexandru Mihai Grumezescu 23. Copper based Nanoparticles as Antimicrobials C. Dendrinou-Samara 24. Antimicrobial Applications of Superparamagnetic Iron Oxide Nanoparticles: Perspectives and Challenges Amedea Barozzi Seabra 25. Silica nanoparticles as a basis for efficacy of antimicrobial drug Alexander Lykov 26. Silver nanoparticles as antimicrobial agents: past, present, and future Luciano Paulino Silva 27. Encapsulation of lethal, functional and therapeutic medicinal nanoparticles and quantum dots for the improved diagnosis and treatment of infection Dipak K. Sarker 28. |
|
Advanced Nanocomposites with Noble Metal Antimicrobial Nanoparticles: how to design a balance among antimicrobial activity, bioactivity and safe delivery to the place of infection Marija Vukomanovi 29. Clinical development in antimicrobial nanomedicine: towards novel solutions Elaine Del-Bel 30. The citation classics in antimicrobial nanostructures Ozcan Konur |
|
Advanced Nanocomposites with Noble Metal Antimicrobial Nanoparticles: how to design a balance among antimicrobial activity, bioactivity and safe delivery to the place of infection Marija Vukomanovi 29. Clinical development in antimicrobial nanomedicine: towards novel solutions Elaine Del-Bel 30. The citation classics in antimicrobial nanostructures Ozcan Konur. |
|
Front Cover; Nanostructures for Antimicrobial Therapy; Nanostructures for Antimicrobial Therapy: Nanostructures in Therapeutic Medicine Series; Copyright; Contents; List of Contributors; Series Foreword; Series Preface; Preface; 1 -- Antimicrobials: Meeting the Challenges of Antibiotic Resistance Through Nanotechnology; 1. INTRODUCTION; 2. CURRENT STATUS OF THE MENACE OF ANTIMICROBIAL RESISTANCE; 3. ANTIMICROBIAL CLASSES AND THEIR CURRENT EFFECTIVENESS WITH RESPECT TO EMERGING DRUG RESISTANCE; 3.1 Classification on the Basis of Spectrum of Activity. |
|
3.2 Classification on the Basis of Nature of Effect3.3 Classification on the Basis of Mode of Action; 3.3.1 Cell Wall Synthesis Inhibitors; 3.3.2 Cell Membrane Function Inhibitors; 3.3.3 Protein Synthesis Inhibitors; 3.3.3.1 Aminoglycosides; 3.3.3.2 Macrolides; 3.3.3.3 Lincosamide; 3.3.3.4 Streptogramins; 3.3.3.5 Chloramphenicol; 3.3.3.6 Tetracycline; 3.3.4 Nucleic Acid Synthesis Inhibitors; 3.3.4.1 Quinolones; 3.3.4.2 Rifamycin; 3.3.5 Metabolic Process Inhibitors; 3.3.5.1 Sulfonamides; 3.3.5.2 Trimethoprim; 4. MICROBIAL RESISTANCE MECHANISM TO ANTIMICROBIALS; 4.1 Antibiotic Inactivation. |
|
4.1.1 Hydrolysis-Based Antibiotic Inactivation4.1.2 Group Transfer-Based Enzymatic Inactivation; 4.1.3 Redox Process-Based Antibiotic Inactivation; 4.1.3.1 Target Site Modification; 4.1.3.2 Efflux Pump-Mediated Resistance; 4.1.3.3 Changes in Outer Membrane Permeability; 5. APPLICATION OF NANOTECHNOLOGY TO COUNTER ANTIMICROBIAL RESISTANCE; 5.1 Nanomaterials as Antimicrobials; 5.1.1 Silver Nanoparticles; 5.1.2 Zinc Oxide Nanoparticles; 5.1.3 Titanium Dioxide Nanoparticles; 5.1.4 Gold Nanoparticles; 5.1.5 Copper Nanoparticles; 5.1.6 Chitosan; 5.1.7 Nitric Oxide-Releasing Nanoparticles. |
|
5.1.8 Carbon Nanotubes6. ROLE OF NANOPARTICLES IN OVERCOMING THE CHALLENGE OF ANTIMICROBIAL DRUG DELIVERY; 6.1 Liposome-Mediated Antimicrobial Delivery; 6.1.1 Polymeric Nanoparticles; 6.1.2 Solid Lipid Nanoparticles; 6.1.3 Dendrimers; 7. CONCLUSIONS; ACKNOWLEDGMENT; REFERENCES; FURTHER READING; 2 -- Nanoantimicrobials: Activity, Benefits, and Weaknesses; 1. INTRODUCTION; 2. NANOPARTICLES AND NANOFORMULATIONS; 3. NANOFORMULATIONS BASED ON ORGANIC ANTIBACTERIAL AGENTS; 4. NANOFORMULATIONS BASED ON INORGANIC MATERIALS WITH ANTIBACTERIAL ACTIVITY; 4.1 Nanoformulations of Silver. |
|
4.2 Nanoformulations of Gold4.3 Nanoformulations of Zinc Oxide; 4.4 Nanoformulations of Copper; 4.5 Nanoformulations of Iron; 5. ANTITUBERCULOSIS-ACTIVE NANOFORMULATIONS; 6. POLYMER MATRICES WITH ANTIMICROBIAL ACTIVITY; 7. RISKS OF APPLICATION OF NANOFORMULATIONS IN THERAPY; 8. CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; 3 -- Sensitive and Selective Assay of Antimicrobials on Nanostructured Materials by Electrochemical Techniques; 1. INTRODUCTION; 2. ANTIMICROBIALS; 2.1 Antibacterials; 2.1.1 Classification of Antibiotics Based on Type of Activity. |
| Summary |
Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues. |
| Bibliography |
Includes bibliographical references and index. |
| Access |
Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK). WlAbNL |
| Terms Of Use |
Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force. WlAbNL |
| Subject |
Anti-infective agents.
|
|
Nanostructures.
|
|
Anti-Infective Agents |
|
Nanostructures |
|
Antiinfectieux.
|
|
Nanostructures.
|
|
MEDICAL -- Pharmacology.
|
|
Anti-infective agents
|
|
Nanostructures
|
| Added Author |
FICAI, ANTON.
|
| Other Form: |
Print version: 0323461522 9780323461528 (OCoLC)974025436 |
| ISBN |
9780323461511 (electronic bk.) |
|
0323461514 (electronic bk.) |
|
0323461522 |
|
9780323461528 |
| Standard No. |
AU@ 000061154825 |
|
CHBIS 011069756 |
|
CHVBK 499783506 |
|
GBVCP 892971037 |
|
UKMGB 018372035 |
|
AU@ 000065061974 |
